ReShape Lifesciences, Inc. (HIND)
Market Open
15 Jun, 14:36
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 18
-0.12
-5.2174%
$
11.88M Market Cap
- P/E Ratio
- Div Yield
4,740 Volume
- Eps
$ 2.3
Previous Close Investors:
Want to track HIND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ReShape Lifesciences, Inc. (HIND) Statistics
Valuation metrics
Market Cap 11.88M
Enterprise value 4.18M
Trailing P/E (ttm) -1.03
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 9.63
Price/Book (mrq) 2.02
Enterprise Value/Revenue 3.11
Enterprise Value/EBITDA -0.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.98K
Average volume (90 days) 28.98K
Price summary
52-Week low 1.75
52-Week high 18.6
Beta -
50-Day moving average 2.14
200-Day moving average 2.82
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 15 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.85%
Operating margin -4.02%
Operational effectiveness
Return on assets -1.3%
Return on equity -3.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.23
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.49
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 4.27%
Book value per share (mrq) 1.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
